Symyx Technologies has joined the Microsoft BioIT Alliance, a cross-industry group working to enhance collaboration among life sciences organisations to accelerate drug discovery and development
"Comprehensive data integration - making complex life sciences data easier to manage and easier to share - requires new levels of cooperation between software companies," said Timothy Campbell, president of Symyx Software.
"Symyx is delighted to be part of Microsoft's BioIT Alliance initiative.
"As a technology leader in integrated laboratory workflow systems, R+D software and research services in the life sciences and related industries, we look forward to working closely with Microsoft's partner community to explore new and better ways of capturing, managing and sharing R+D data.
"Through improved collaboration, multidisciplinary R+D organisations can solve critical life sciences problems more quickly and bring new products to market with less risk".
Rudy Potenzone, worldwide industry technology strategist for pharmaceuticals and BioIT Alliance coordinator, said: "We are very pleased to welcome Symyx to the BioIT Alliance.
"Its broad experience and contribution to this community will help the alliance and its members as we look to expand our activities in the coming months".
The BioIT Alliance is designed to enable collaboration among organisations in the life sciences field in order to shorten the time between discovery of new biological data and the application of that knowledge to human health.
Symyx will work with other alliance members to consider innovative ways to address the challenges of data integration, collaboration, and knowledge management and use Microsoft technology to reduce costs, streamline research and market products more effectively.
